The original medulloblastoma exome sequencing led to the discovery of frequent mutations in the histone lysine methyltransferase gene KMT2D/MLL2 and its homolog KMT2C/MLL3, which were not previously linked to cancer [13]. Here, KMT2D is linked to medulloblastoma.